http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013263817-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd1fcf383108255c0c37f8a99d0df33f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70755deabd1145caec921533a53d25e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e8d3c537195f8979793af5118f13c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfcfa5084ac8af3644ce1f7d1576fec6 |
| publicationDate | 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013263817-A1 |
| titleOfInvention | High affinity anti-human IgE antibodies |
| abstract | HIGH AFFINITY ANTI-HUMAN IGE ANTIBODIES The invention relates to high affinity human monoclonal antibodies, particularly those directed against isotypic determinants of immunoglobulin E (IgE), as well as direct equivalents and derivatives of these antibodies. These antibodies bind to their respective target with an affinity at least 100 fold greater than the original parent antibody. These antibodies are useful for diagnostics, prophylaxis and treatment of disease. |
| priorityDate | 2003-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 345.